Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin1

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Artery Disease, Diabetes, and Chronic Kidney Disease

(2012) James Shepherd et al.   MAYO CLINIC PROCEEDINGS

Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKD

(2009) Michael J. Koren et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)

(2009) Helen M. Colhoun et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease

(2008) Linda F. Fried   KIDNEY INTERNATIONAL

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE